Nucleus Software Exports Limited carries a market capitalization of 19.14B, placing it among publicly traded companies globally. Its enterprise value stands at 14.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 19.14B |
| Enterprise Value | 14.95B |
Nucleus Software Exports Limited currently has 26.33M shares outstanding.
| Shares Outstanding | 26.33M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Nucleus Software Exports Limited trades at a trailing price-to-earnings ratio of 16.30. The price-to-sales ratio is 2.17, and the price-to-book ratio stands at 72.27.
| PE Ratio | 16.30 |
| PS Ratio | 2.17 |
| PB Ratio | 72.27 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Nucleus Software Exports Limited trades at an EV/EBITDA multiple of 13.70 and an EV/FCF ratio of 1,361.01. The EV/Sales ratio of 1.71 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.70 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.71 |
| EV / EBITDA | 13.70 |
| EV / EBIT | 13.70 |
| EV / FCF | 1,361.01 |
Nucleus Software Exports Limited maintains a current ratio of 2.09, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.94, indicating moderate leverage, while an interest coverage ratio of 77.36 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.09 |
| Quick Ratio | 1.48 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 0.08 |
| Interest Coverage | 77.36 |
Nucleus Software Exports Limited posts a return on equity of 28.49 and a return on invested capital of 9.70.
| Return on Equity (ROE) | 28.49 |
| Return on Assets (ROA) | 9.65 |
| Return on Invested Capital (ROIC) | 9.70 |
| Return on Capital Employed (ROCE) | 28.39 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Nucleus Software Exports Limited has paid 331.40M in income taxes, reflecting an effective tax rate of 22.11.
| Income Tax | 331.40M |
| Effective Tax Rate | 22.11 |
Nucleus Software Exports Limited's stock has declined approximately -41.17718% over the past 52 weeks. The 50-day moving average sits at 791.70, while the 200-day moving average is 897.97.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.17718% |
| 50-Day Moving Average | 791.70 |
| 200-Day Moving Average | 897.97 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Nucleus Software Exports Limited generated 8.76B in revenue and converted that into 1.17B in net income, yielding earnings per share of 44.34. EBITDA reached 1.09B, while operating income came in at 1.09B.
| Revenue | 8.76B |
| Gross Profit | 2.87B |
| Operating Income | 1.09B |
| Pretax Income | 1.50B |
| Net Income | 1.17B |
| EBITDA | 1.09B |
| EBIT | 1.09B |
| Earnings Per Share (EPS) | 44.34 |
Nucleus Software Exports Limited holds 4.17B in cash and equivalents against 85.50M in total debt, resulting in a net debt position of -800.10M. Total book value stands at 263.30M, with working capital of 3.07B providing operational flexibility.
| Cash & Cash Equivalents | 4.17B |
| Total Debt | 85.50M |
| Net Debt | -800.10M |
| Equity (Book Value) | 263.30M |
| Book Value Per Share | 10.00 |
| Working Capital | 3.07B |
Nucleus Software Exports Limited operates with a gross margin of 32.72, reflecting its pricing power and cost economics. The operating margin of 12.45 and net profit margin of 13.33 provide insight into operational efficiency.
| Gross Margin | 32.72 |
| Operating Margin | 12.45 |
| Pretax Margin | 17.11 |
| Profit Margin | 13.33 |
| EBITDA Margin | 12.45 |
Nucleus Software Exports Limited's most recent stock split took place on August 3, 2007 with a 1:2 split ratio.
| Last Split Date | 8/3/2007 |
| Split Ratio | 1:2 |
Nucleus Software Exports Limited posts an Altman Z-Score of 4.45, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.45 |